413 related articles for article (PubMed ID: 24821922)
1. Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
Saez-Cirion A; Jacquelin B; Barré-Sinoussi F; Müller-Trutwin M
Philos Trans R Soc Lond B Biol Sci; 2014; 369(1645):20130436. PubMed ID: 24821922
[TBL] [Abstract][Full Text] [Related]
2. The Hitchhiker Guide to CD4
Le Hingrat Q; Sereti I; Landay AL; Pandrea I; Apetrei C
Front Immunol; 2021; 12():695674. PubMed ID: 34367156
[TBL] [Abstract][Full Text] [Related]
3. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
mBio; 2017 May; 8(3):. PubMed ID: 28465428
[TBL] [Abstract][Full Text] [Related]
4. Elite control of HIV: is this the right model for a functional cure?
Cockerham LR; Hatano H
Trends Microbiol; 2015 Feb; 23(2):71-5. PubMed ID: 25487109
[TBL] [Abstract][Full Text] [Related]
5. Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies.
Huot N; Bosinger SE; Paiardini M; Reeves RK; Müller-Trutwin M
Front Immunol; 2018; 9():780. PubMed ID: 29725327
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
García M; López-Fernández L; Mínguez P; Morón-López S; Restrepo C; Navarrete-Muñoz MA; López-Bernaldo JC; Benguría A; García MI; Cabello A; Fernández-Guerrero M; De la Hera FJ; Estrada V; Barros C; Martínez-Picado J; Górgolas M; Benito JM; Rallón N
J Mol Med (Berl); 2020 Aug; 98(8):1093-1105. PubMed ID: 32556382
[TBL] [Abstract][Full Text] [Related]
7. Post-Treatment Controllers: Role in HIV "Cure" Research.
Cockerham LR; Hatano H; Deeks SG
Curr HIV/AIDS Rep; 2016 Feb; 13(1):1-9. PubMed ID: 26781112
[TBL] [Abstract][Full Text] [Related]
8. HIV controllers: a multifactorial phenotype of spontaneous viral suppression.
Thèze J; Chakrabarti LA; Vingert B; Porichis F; Kaufmann DE
Clin Immunol; 2011 Oct; 141(1):15-30. PubMed ID: 21865089
[TBL] [Abstract][Full Text] [Related]
9. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
[TBL] [Abstract][Full Text] [Related]
11. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
[TBL] [Abstract][Full Text] [Related]
12. Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
Breed MW; Elser SE; Torben W; Jordan AP; Aye PP; Midkiff C; Schiro F; Sugimoto C; Alvarez-Hernandez X; Blair RV; Somasunderam A; Utay NS; Kuroda MJ; Pahar B; Wiseman RW; O'Connor DH; LaBranche CC; Montefiori DC; Marsh M; Li Y; Piatak M; Lifson JD; Keele BF; Fultz PN; Lackner AA; Hoxie JA
J Virol; 2015 Oct; 89(20):10156-75. PubMed ID: 26223646
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
[TBL] [Abstract][Full Text] [Related]
14. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
J Virol; 2019 May; 93(10):. PubMed ID: 30814287
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Profiling of Latently SIV-Infected CD4
Tokarev A; Machmach K; Creegan M; Kim D; Eller MA; Bolton DL
Microbiol Spectr; 2022 Jun; 10(3):e0060422. PubMed ID: 35510859
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunology of HIV infection.
Xu H; Wang X; Veazey RS
Immunol Rev; 2013 Jul; 254(1):10-33. PubMed ID: 23772612
[TBL] [Abstract][Full Text] [Related]
17. Immune Control of HIV.
Balasubramaniam M; Pandhare J; Dash C
J Life Sci (Westlake Village); 2019 Jun; 1(1):4-37. PubMed ID: 31468033
[TBL] [Abstract][Full Text] [Related]
18. Advances in Developing CAR T-Cell Therapy for HIV Cure.
Qi J; Ding C; Jiang X; Gao Y
Front Immunol; 2020; 11():361. PubMed ID: 32210965
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques.
Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T
J Gen Virol; 2007 Feb; 88(Pt 2):652-659. PubMed ID: 17251584
[TBL] [Abstract][Full Text] [Related]
20. Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies.
Woldemeskel BA; Kwaa AK; Blankson JN
EBioMedicine; 2020 Dec; 62():103118. PubMed ID: 33181459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
